Artificial intelligence methods for a Bayesian epistemology-powered evidence evaluation.
Journal:
Journal of evaluation in clinical practice
Published Date:
Feb 11, 2021
Abstract
RATIONALE, AIMS AND OBJECTIVES: The diversity of types of evidence (eg, case reports, animal studies and observational studies) makes the assessment of a drug's safety profile into a formidable challenge. While frequentist uncertain inference struggles in aggregating these signals, the more flexible Bayesian approaches seem better suited for this quest. Artificial Intelligence (AI) offers great promise to these approaches for information retrieval, decision support, and learning probabilities from data.